February 28, 2017
Astellas Pharma has granted exclusive rights in Japan to Kyowa Pharmaceutical Industry for the distribution and promotion of extended-release tablets of quetiapine fumarate, which is pending approval for the treatment of depressive symptoms associated with bipolar disorder. Under the deal...read more